BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22670887)

  • 1. Leaving nothing to chance: how to randomize a clinical trial.
    Toltl LJ; Arnold DM
    Transfusion; 2012 Dec; 52(12):2513-5. PubMed ID: 22670887
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 4. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 5. Limitations of randomized clinical trials in chronic diseases: explanations and recommendations.
    Pincus T
    Adv Mind Body Med; 2002; 18(2):14-21. PubMed ID: 12629874
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical appraisal. 5. Randomised controlled trials: questions for valid evidence.
    Nelson EA
    NT Learn Curve; 1999 Jul; 3(5):6-8. PubMed ID: 10795227
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fables or foibles: inherent problems with RCTs.
    Rosner A
    J Manipulative Physiol Ther; 2003 Sep; 26(7):460-7. PubMed ID: 12975633
    [No Abstract]   [Full Text] [Related]  

  • 9. Korn and Freidlin's misunderstanding of the null hypothesis significance testing procedure.
    Trafimow D; Rice S
    Am J Bioeth; 2011 Mar; 11(3):15-6. PubMed ID: 21400377
    [No Abstract]   [Full Text] [Related]  

  • 10. Reporting the results of a study that did not go according to plan.
    Houle TT
    Anesthesiology; 2009 May; 110(5):957-8. PubMed ID: 19387171
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized clinical trials in surgery: why do we need them?
    Balch CM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):241-2. PubMed ID: 16872941
    [No Abstract]   [Full Text] [Related]  

  • 12. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 13. Eroding precision in scientific communications: contagion from "the real world".
    Lyles A
    Clin Ther; 2007 Jan; 29(1):182. PubMed ID: 17379059
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimal designs for two-arm, phase II clinical trial design with multiple constraints.
    Mayo MS; Mahnken JD; Soong SJ
    J Biopharm Stat; 2010 Jan; 20(1):106-24. PubMed ID: 20077252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Education section - designing a "placebo" to help define the intervention.
    J Evid Based Med; 2011 Nov; 4(4):261-2. PubMed ID: 23672759
    [No Abstract]   [Full Text] [Related]  

  • 16. What's the rush? Internal validity is not a trivial pursuit.
    Kovach CR
    Res Gerontol Nurs; 2010 Jan; 3(1):2-4. PubMed ID: 20128537
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CONSORT statement: Progress in clinical research in pediatric surgery.
    Moss RL
    J Pediatr Surg; 2001 Dec; 36(12):1739-42. PubMed ID: 11733895
    [No Abstract]   [Full Text] [Related]  

  • 19. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
    Korn EL; Freidlin B
    Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.